Klein Lloyd W, Nathan Sandeep, Maehara Akiko, Messenger John, Mintz Gary S, Ali Ziad A, Rymer Jennifer, Sandoval Yader, Al-Azizi Karim, Mehran Roxana, Rao Sunil V, Lotfi Amir
Division of Cardiology, University of California, San Francisco, San Francisco, California.
Section of Cardiology, Department of Medicine, University of Chicago, Chicago, Illinois.
J Soc Cardiovasc Angiogr Interv. 2023 May 18;2(4):100971. doi: 10.1016/j.jscai.2023.100971. eCollection 2023 Jul-Aug.
Stent failure remains the major drawback to the use of coronary stents as a revascularization strategy. Recent advances in imaging have substantially improved our understanding of the mechanisms underlying these occurrences, which have in common numerous clinical risk factors and mechanical elements at the time of stent implantation. In-stent restenosis remains a common clinical problem despite numerous improvements in-stent design and polymer coatings over the past 2 decades. It generates significant health care cost and is associated with an increased risk of death and rehospitalization. Stent thrombosis causes abrupt closure of the stented artery and therefore carries a high risk of myocardial infarction and death. This Society for Cardiovascular Angiography & Interventions (SCAI) Expert Consensus Statement suggests updated practical algorithmic approaches to in-stent restenosis and stent thrombosis. A pragmatic outline of assessment and management of patients presenting with stent failure is presented. A new SCAI classification that is time-sensitive with mechanistic implications of in-stent restenosis is proposed. Emphasis is placed on frequent use of intracoronary imaging and assessment of timing to determine the precise etiology because that information is crucial to guide selection of the best treatment option. SCAI recommends image-guided coronary stenting at the time of initial implantation to minimize the occurrence of stent failure. When in-stent restenosis and stent thrombosis are encountered, imaging should be strongly considered to optimize the subsequent approach.
支架失败仍然是将冠状动脉支架作为血运重建策略使用的主要缺点。成像技术的最新进展极大地增进了我们对这些情况潜在机制的理解,这些机制在支架植入时具有众多临床风险因素和机械因素。尽管在过去20年里支架设计和聚合物涂层有了诸多改进,但支架内再狭窄仍然是一个常见的临床问题。它产生了巨大的医疗成本,并与死亡和再次住院风险增加相关。支架血栓形成会导致支架置入动脉突然闭塞,因此具有很高的心肌梗死和死亡风险。心血管造影和介入学会(SCAI)专家共识声明提出了针对支架内再狭窄和支架血栓形成的更新的实用算法方法。本文给出了支架失败患者评估和管理的实用概述。提出了一种对时间敏感且具有支架内再狭窄机制意义的新SCAI分类。重点强调频繁使用冠状动脉内成像和评估时间以确定确切病因,因为该信息对于指导选择最佳治疗方案至关重要。SCAI建议在初次植入时采用影像引导的冠状动脉支架置入术,以尽量减少支架失败的发生。当遇到支架内再狭窄和支架血栓形成时,应强烈考虑进行成像以优化后续治疗方法。